Below are the top drug related product stocks on the NYSE and the NASDAQ in terms of free cash flow.
The trailing-twelve-month free cash flow at Herbalife Ltd HLF is $230.7 million. HLF’s PEG ratio is 0.94.
The trailing-twelve-month free cash flow at NBTY Inc NTY is $153.2 million. Analysts at Barclays Capital upgraded NTY from “equal weight” to “overweight.”
The trailing-twelve-month free cash flow at Perrigo Company PRGO is $137 million. Analysts at Caris & Company upgraded PRGO from “average” to “above average.”
The trailing-twelve-month free cash flow at Salix Pharmaceuticals Ltd SLXP is $57.7 million. Analysts at Thomas Weisel initiated coverage of SLXP with an “overweight” rating.
Trading Ideas.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Long IdeasUpgradesTechnicalsInitiationMarketsAnalyst RatingsTrading IdeasConsumer StaplesDrug Related ProductsHealth CareHighest Free Cash FlowPersonal ProductsPharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in